No Data
Intelligent Hong Kong Stock Shareholder Equity Disclosure | November 15th
Hong Kong shareholder equity disclosure | November 15th
ssy group (02005.HK) has increased its shareholding by 1 million shares, and director and chairman Qu Jiguang also serves as the executive director.
According to the latest equity disclosure information from the Hong Kong Stock Exchange on November 14, 2024, ssy group (02005.HK) announced that director, chairman, and CEO Qu Jiguang purchased 1 million shares at an average price of 3.8166 Hong Kong dollars per share, with a total investment of approximately 3.8166 million Hong Kong dollars. Following the shareholding, Qu Jiguang's latest shareholding is 1,140,466,000 shares, increasing his ownership percentage from 38.52% to 38.56%.
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
Multiple bullish factors boost pharmaceutical Hong Kong stocks. Institutions say they still face this risk in the short term.
①What are the policy measures to support the field of innovative drugs? ②What unfavorable effects on domestic pharmaceutical stocks might Trump's election bring about?
As SSY Group (HKG:2005) Ascends 4.8% This Past Week, Investors May Now Be Noticing the Company's Five-year Earnings Growth
SSY Group Gets Production, Registration Go-Ahead for Blood Pressure Maintaining Drug From Chinese Regulator
Earnings Are Growing at SSY Group (HKG:2005) but Shareholders Still Don't Like Its ProspectsNo Data
No Data
